Drug profile · INN
pralatrexate
FOLOTYN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
pralatrexate (FOLOTYN) is an FDA-listed pharmaceutical active ingredient. Associated with Mundipharma Pty Limited. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN pralatrexate
Brand FOLOTYN
Route INJECTION
Formulation INJECTABLE
ATC code L01BA05
Originator Mundipharma Pty Limited
Frequently asked questions
What is pralatrexate?
pralatrexate (FOLOTYN) is an FDA-listed pharmaceutical active ingredient. Associated with Mundipharma Pty Limited. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for pralatrexate?
FOLOTYN is a marketed brand name for pralatrexate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pralatrexate?
pralatrexate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.